These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial. Niederman MS; Alder J; Bassetti M; Boateng F; Cao B; Corkery K; Dhand R; Kaye KS; Lawatscheck R; McLeroth P; Nicolau DP; Wang C; Wood GC; Wunderink RG; Chastre J Lancet Infect Dis; 2020 Mar; 20(3):330-340. PubMed ID: 31866328 [TBL] [Abstract][Full Text] [Related]
4. Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia. Hua F; Xie H; Worthington HV; Furness S; Zhang Q; Li C Cochrane Database Syst Rev; 2016 Oct; 10(10):CD008367. PubMed ID: 27778318 [TBL] [Abstract][Full Text] [Related]
5. A randomized double-blind placebo-controlled dose-escalation phase 1 study of aerosolized amikacin and fosfomycin delivered via the PARI investigational eFlow® inline nebulizer system in mechanically ventilated patients. Montgomery AB; Vallance S; Abuan T; Tservistas M; Davies A J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):441-8. PubMed ID: 24383962 [TBL] [Abstract][Full Text] [Related]
6. Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia. Shi Z; Xie H; Wang P; Zhang Q; Wu Y; Chen E; Ng L; Worthington HV; Needleman I; Furness S Cochrane Database Syst Rev; 2013 Aug; (8):CD008367. PubMed ID: 23939759 [TBL] [Abstract][Full Text] [Related]
7. Prevention of Early Ventilator-Associated Pneumonia after Cardiac Arrest. François B; Cariou A; Clere-Jehl R; Dequin PF; Renon-Carron F; Daix T; Guitton C; Deye N; Legriel S; Plantefève G; Quenot JP; Desachy A; Kamel T; Bedon-Carte S; Diehl JL; Chudeau N; Karam E; Durand-Zaleski I; Giraudeau B; Vignon P; Le Gouge A; N Engl J Med; 2019 Nov; 381(19):1831-1842. PubMed ID: 31693806 [TBL] [Abstract][Full Text] [Related]
8. A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram-Negative Ventilator-Associated Pneumonia: IASIS Trial. Kollef MH; Ricard JD; Roux D; Francois B; Ischaki E; Rozgonyi Z; Boulain T; Ivanyi Z; János G; Garot D; Koura F; Zakynthinos E; Dimopoulos G; Torres A; Danker W; Montgomery AB Chest; 2017 Jun; 151(6):1239-1246. PubMed ID: 27890714 [TBL] [Abstract][Full Text] [Related]
9. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
10. [In a patient undergoing mechanical ventilation for at least 3 days, does a 3-day course of inhaled amikacin reduce the incidence of ventilator-associated pneumonia compared to placebo, and is it safe?]. Lanthier L; Mayette M; Plourde MÉ; Cauchon M Rev Med Interne; 2024 Jan; 45(1):55-56. PubMed ID: 38142212 [No Abstract] [Full Text] [Related]
11. Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial. François B; Jafri HS; Chastre J; Sánchez-García M; Eggimann P; Dequin PF; Huberlant V; Viña Soria L; Boulain T; Bretonnière C; Pugin J; Trenado J; Hernandez Padilla AC; Ali O; Shoemaker K; Ren P; Coenjaerts FE; Ruzin A; Barraud O; Timbermont L; Lammens C; Pierre V; Wu Y; Vignaud J; Colbert S; Bellamy T; Esser MT; Dubovsky F; Bonten MJ; Goossens H; Laterre PF; Lancet Infect Dis; 2021 Sep; 21(9):1313-1323. PubMed ID: 33894131 [TBL] [Abstract][Full Text] [Related]
12. Ceftriaxone to prevent early ventilator-associated pneumonia in patients with acute brain injury: a multicentre, randomised, double-blind, placebo-controlled, assessor-masked superiority trial. Dahyot-Fizelier C; Lasocki S; Kerforne T; Perrigault PF; Geeraerts T; Asehnoune K; Cinotti R; Launey Y; Cottenceau V; Laffon M; Gaillard T; Boisson M; Aleyrat C; Frasca D; Mimoz O; Lancet Respir Med; 2024 May; 12(5):375-385. PubMed ID: 38262428 [TBL] [Abstract][Full Text] [Related]
13. Nebulized Versus IV Amikacin as Adjunctive Antibiotic for Hospital and Ventilator-Acquired Pneumonia Postcardiac Surgeries: A Randomized Controlled Trial. Hassan NA; Awdallah FF; Abbassi MM; Sabry NA Crit Care Med; 2018 Jan; 46(1):45-52. PubMed ID: 28857848 [TBL] [Abstract][Full Text] [Related]
14. Aerosolized Amikacin as Adjunctive Therapy of Ventilator-associated Pneumonia Caused by Multidrug-resistant Gram-negative Bacteria: A Single-center Randomized Controlled Trial. Liu C; Zhang YT; Peng ZY; Zhou Q; Hu B; Zhou H; Li JG Chin Med J (Engl); 2017 May; 130(10):1196-1201. PubMed ID: 28485320 [TBL] [Abstract][Full Text] [Related]